<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
PLRX
Pliant Therapeutics
$
()


  • Pliant Therapeutics announces accelerated bexotegrast development plan

    3/12/2024 - 07:48am
  • Pliant Therapeutics price target lowered by $3 at RBC Capital, here's why

    2/28/2024 - 07:40am
  • Pliant Therapeutics reports Q4 EPS (69c), consensus (81c)

    2/27/2024 - 16:24pm
  • Pliant Therapeutics price target lowered by $5 at Canaccord, here's why

    2/8/2024 - 07:19am
  • Pliant Therapeutics price target lowered by $2 at Oppenheimer, here's why

    2/6/2024 - 07:29am
  • Pliant Therapeutics price target lowered by $4 at H.C. Wainwright, here's why

    2/5/2024 - 06:14am
  • Pliant Therapeutics announces data from INTEGRIS-PSC Phase 2a trial

    2/4/2024 - 16:42pm
  • The biotech stocks to own in 2024, according to Piper Sandler

    1/2/2024 - 12:13pm
  • Pliant Therapeutics initiated with an Overweight at Wells Fargo

    12/7/2023 - 17:29pm
  • Pliant Therapeutics initiated with an Overweight at Wells Fargo

    12/7/2023 - 16:29pm
  • Cantor Fitzgerald biotech analysts hold an analyst/industry conference call

    11/17/2023 - 09:45am
  • Cantor Fitzgerald biotech analysts hold an analyst/industry conference call

    11/17/2023 - 04:55am
  • Cantor Fitzgerald biotech analysts hold an analyst/industry conference call

    11/10/2023 - 15:27pm
  • Pliant Therapeutics price target lowered to $49 from $52 at Oppenheimer

    11/10/2023 - 07:07am
  • Pliant Therapeutics price target lowered to $45 from $50 at Citi

    11/10/2023 - 06:20am
dynamic_feed Breaking News